CT Cardiomegaly vs ZEUS System (Zio Watch)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Innolitics
VS
by iRhythm Technologies, Inc.

AI Verdict

Tool A, Innolitics' CT Cardiomegaly, is an AI-powered command-line software for automated cardiothoracic ratio measurement from CT chest images, focusing on structural heart assessment. In contrast, Tool B, iRhythm Technologies' ZEUS System (Zio Watch), is an AI-powered wearable for long-term continuous cardiac monitoring, designed to detect and characterize arrhythmias like Atrial Fibrillation. While both are FDA-cleared cardiology AI tools, they address distinct clinical needs: one for static image-based structural analysis and the other for dynamic, continuous electrical activity monitoring.

Choose CT Cardiomegaly if…

Choose CT Cardiomegaly if you need to quantitatively assess cardiomegaly from existing CT chest images. This command-line software is ideal for radiologists and cardiologists seeking automated, precise measurements of cardiothoracic ratios to aid in the diagnosis and monitoring of heart enlargement from static imaging studies.

View CT Cardiomegaly →

Choose ZEUS System (Zio Watch) if…

Choose ZEUS System (Zio Watch) if you require long-term continuous cardiac monitoring to detect and characterize arrhythmias, particularly Atrial Fibrillation. This wearable device and cloud-based system is best suited for identifying intermittent or paroxysmal arrhythmias that might be missed during a shorter observation period, offering actionable insights for patient management through extended rhythm analysis.

View ZEUS System (Zio Watch) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CT Cardiomegaly ZEUS System (Zio Watch)
Pricing Fixed-fee Contact vendor
Deployment Docker Container (Ubuntu 20.04), command-line software Cloud-based system with a wearable device
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ZEUS System (Zio Watch)

Tool B offers a comprehensive and user-friendly ecosystem, including a wearable device, a cloud-based portal, and mobile apps for both providers and patients, facilitating broad accessibility and ease of use. In contrast, Tool A is described as command-line software, which typically requires more technical proficiency and offers a less intuitive user experience for a general clinical audience.

Clinical Value

ZEUS System (Zio Watch)

Tool B provides long-term continuous cardiac monitoring for detecting and characterizing AFib and other arrhythmias, offering ongoing actionable insights with high physician agreement (99%). While Tool A offers valuable quantitative data for cardiomegaly detection, Tool B's continuous monitoring for a broader range of arrhythmias potentially offers a more significant and proactive impact on patient management and outcomes.

Pricing & Value

Tie

Both tools require direct contact with the vendor for pricing information, making it impossible to assess their relative value without specific cost details. The lack of transparent pricing for either product prevents a meaningful head-to-head comparison on this dimension.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness, being FDA-cleared, HIPAA compliant, and offering Business Associate Agreements (BAAs). Tool A's Docker container deployment offers flexibility for IT integration, while Tool B's cloud-based system is also a robust and scalable solution for healthcare enterprises.

Innovation

ZEUS System (Zio Watch)

Tool B showcases greater innovation by integrating a wearable biosensor for continuous ECG and PPG data collection with an AI-powered cloud system for advanced arrhythmia detection and analysis. This combination of hardware, long-term monitoring, and AI for proactive detection represents a more novel and comprehensive approach compared to Tool A's automation of a specific measurement from existing CT images.

Support & Docs

ZEUS System (Zio Watch)

Tool B explicitly mentions a 'ZioSuite portal and provider mobile app for report interpretation and patient management' and a 'MyZio patient app for digital symptom logging, educational content, and reminders,' indicating a robust and accessible support ecosystem. Tool A, being command-line software, implies a reliance on technical documentation and direct vendor contact, with less explicit mention of comprehensive user support resources.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CT Cardiomegaly ZEUS System (Zio Watch)
Name CT Cardiomegaly ZEUS System (Zio Watch)
Company Innolitics iRhythm Technologies
Primary Function/Purpose Automatically measures cardiothoracic ratio from CT chest images, assisting physicians in cardiomegaly detection with quantitative data. AI-powered wearable for long-term continuous cardiac monitoring, specifically designed to detect and characterize Atrial Fibrillation (AFib) and other cardiac arrhythmias.
Categories Cardiology AI, Radiology & Imaging AI Cardiology AI, Wearables & Remote Monitoring (RPM)
Specialties Cardiology, Radiology Cardiology, Family Medicine, Internal Medicine
Key Output/Detection Automatic cardiothoracic ratio measurement, segmentation of heart and thoracic cavity, linear and area-based cardiothoracic ratios, PDF and JSON reports. Continuous ECG and PPG data collection, AI-powered arrhythmia detection and analysis, long-term continuous monitoring (up to 14 days), detects and characterizes AFib burden, clinically actionable reports.

Videos

Demos, reviews, and walkthroughs featuring CT Cardiomegaly and ZEUS System (Zio Watch).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Innolitics' CT Cardiomegaly assists physicians in cardiomegaly detection by automatically measuring the cardiothoracic ratio from CT chest images. The ZEUS System (Zio Watch) by iRhythm Technologies is designed for long-term continuous cardiac monitoring to detect and characterize Atrial Fibrillation (AFib) and other cardiac arrhythmias.
CT Cardiomegaly processes CT chest images to perform its analysis. In contrast, the ZEUS System (Zio Watch) collects continuous ECG and PPG data via a wearable biosensor.
CT Cardiomegaly provides quantitative data to assist in the detection of cardiomegaly. The ZEUS System (Zio Watch) is specifically designed to detect and characterize Atrial Fibrillation (AFib) burden and other cardiac arrhythmias.
CT Cardiomegaly performs an analysis on static CT chest images to provide measurements. The ZEUS System (Zio Watch) offers long-term continuous cardiac monitoring for up to 14 days using a wearable biosensor.
CT Cardiomegaly outputs PDF and JSON reports containing linear and area-based cardiothoracic ratios. The ZEUS System (Zio Watch) provides clinically actionable reports through its cloud-based data analytics and the ZioSuite portal and provider mobile app.

Backers

Who funded each tool's parent company.

AI Tool Finder
AI-powered search. Results may not be comprehensive.